Australia is eagerly awaiting the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, this https://montylaqb634290.buscawiki.com/2587181/this_new_drug_retatrutide_australia_a_promising_hope_for_losing_weight